1,000
Participants
Start Date
October 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
PB127 for Injectable Suspension
0.062 mg/kg continuous IV infusion (100-250 mL/hr) during echocardiography, not to exceed 60 minutes infusion, single dose.
St. Luke's Roosevelt Hospital Echocardiography Lab, New York
North Shore University Hospital, Manhasset
Stonybrook University Medical Center, Stony Brook
University of Pittsburgh Cardiovascular Institute, Pittsburgh
Alfieri Cardiology, Newark
Washington Hospital Center Cardiovascular Research Institute, Washington D.C.
Carolina Cardiology Associates, High Point
Duke University Medical Center, Durham
Western Baptist Hospital The Heart Group, Paducah
Ohio State University College of Medicine and Public Health, Columbus
The Cleveland Clinic Foundation Department of Cardiology, Cleveland
Mayo Clinic Department of Cardiology, Rochester
Northwestern University Feinberg School of Medicine, Chicago
St. Louis University Medical Center, St Louis
Cardiovascular Consultants, Kansas City
The Center for Cardiovascular Studies Kramer & Crouse Cardiology, Shawnee Mission
Midwest Cardiology Associates, Overland Park
Consultants in Cardiology, Fort Worth
Methodist DeBakery Heart Center Cardiovascular Imaging Institute, Houston
University of Texas Health Science Center Memorial Hermann Heart & Vascular Institute, Houston
University of Texas Division of Cardiology, Galveston
Seton Healthcare Network Brackenridge Hospital, Austin
Austin Heart, Austin
University of Arizona Saver Heart Clinic, Tucson
Cedars Sinai Medical Center Division of Cardiology, Los Angeles
Long Beach VA Medical Center Cardiology Division, Long Beach
University of California San Diego Division of Cardiology, San Diego
Cardiovascular Associates of the Peninsula, Burlingame
San Francisco VA Medical Center NCIRE, San Francisco
Sutter Roseville Medical Center, Roseville
Harborview Medical Center Department of Cardiology, Seattle
Heart Clinics Northwest, Spokane
Inland Cardiology, Spokane
Northwest Cardiovascular Research Institute Spokane Cardiology, Spokane
Connecticut Clinical Research, Bridgeport
Androscoggin Cardiovascular Associates, Auburn
Maine Cardiology Associates, South Portland
Brigham & Women's Hosptial, Boston
Henry Ford Hospital, Detroit
University of Oklahoma Health Sciences Center VA Medical Center, Oklahoma City
Lead Sponsor
Point Biomedical
INDUSTRY